Abstract | Cancer ÃÂàis ÃÂàthe ÃÂàleading ÃÂàcause ÃÂàof ÃÂàdeath ÃÂàin ÃÂàIndonesia. ÃÂàGenerally, ÃÂàcancer ÃÂàtherapy ÃÂàuseÃÂàchemotherapy, ÃÂàradiation, ÃÂàsurgery ÃÂàor ÃÂàcombination ÃÂàof ÃÂàthose. ÃÂàVarious ÃÂàside ÃÂàeffects ÃÂàcaused ÃÂàbyÃÂàcancer ÃÂàtherapy ÃÂàmake ÃÂàthe ÃÂàuse ÃÂàof ÃÂàadditional ÃÂàdrugs. ÃÂàThis ÃÂàleads ÃÂàto ÃÂàan ÃÂàincrease ÃÂàin ÃÂàtotal ÃÂàcostÃÂàincurred ÃÂàto ÃÂàcancer ÃÂàpatients. ÃÂàThe ÃÂàpurpose ÃÂàof ÃÂàthis ÃÂàstudy ÃÂàwas ÃÂàto ÃÂàdescribe ÃÂàthe ÃÂàtreatment ÃÂàofÃÂàcancer ÃÂàtherapyâÃÂÃÂs side effects ÃÂàas ÃÂàwell ÃÂàas ÃÂàthe ÃÂàaverage ÃÂàcost ÃÂàof ÃÂàside ÃÂàeffects ÃÂàtreatment, ÃÂàand ÃÂàitsÃÂàpercentage ÃÂàin ÃÂàthe ÃÂàtotal ÃÂàcost ÃÂàof ÃÂàcancer ÃÂàpatients ÃÂàin ÃÂàRumah ÃÂàSakit ÃÂàMargono ÃÂàSoekarjo. ÃÂàThisÃÂàresearch was a descriptive study with retrospective data ÃÂàby total sampling method obtainedÃÂàfrom ÃÂàpatientsâÃÂàÃÂàmedical ÃÂàand ÃÂàreceipts ÃÂàrecords ÃÂàof ÃÂàfive ÃÂàmost ÃÂàcommon ÃÂàcancers ÃÂà(breast,ÃÂànasopharynx, ÃÂàNon ÃÂàHodgkins ÃÂàLhympoma ÃÂà(NHL), ÃÂàovarian, ÃÂàand ÃÂàcervix) ÃÂàduring ÃÂàJanuary-December 2010. The average cost of ÃÂàpatientâÃÂÃÂs side effects treatment was calculated by theÃÂàaverage ÃÂàcost ÃÂàof ÃÂàside ÃÂàeffects ÃÂàcompared ÃÂàto ÃÂàthe ÃÂàaverage ÃÂàtotal ÃÂàdirect ÃÂàcosts ÃÂàincurred ÃÂàto ÃÂàcancerÃÂàpatients. ÃÂàThe ÃÂàsamples ÃÂàwas ÃÂàobtained ÃÂàfrom ÃÂàthe ÃÂàpopulation ÃÂàof ÃÂà2261 ÃÂàpatients ÃÂàwho ÃÂàmet ÃÂàtheÃÂàinclusion criteria, that are 73 patients consist of 62 female patients and 11 male patients. TheÃÂàmost ÃÂàcommon ÃÂàside ÃÂàeffects ÃÂàof ÃÂàcancer ÃÂàtherapy ÃÂàwere ÃÂànausea ÃÂàand ÃÂàvomiting ÃÂà(59.80%), ÃÂànausea-vomiting, ÃÂàanemia, ÃÂàand ÃÂàpain ÃÂà(16.44%), ÃÂàand ÃÂànausea-vomiting ÃÂàand ÃÂàanemia ÃÂà(15.07%). ÃÂàThe ÃÂàmostÃÂàused therapy was vitamin B complex followed by histamine-2 inhibitor. The average cost ofÃÂàside effects for breast cancer was Rp 1,715,373 (8.73%), nasopharynx was Rp 1,149,049 (6.98ÃÂà%); ÃÂàNHL ÃÂàwas ÃÂàRp ÃÂà360,778 ÃÂà(1.97 ÃÂà%); ÃÂàovary ÃÂàwas ÃÂàRp ÃÂà911,118 ÃÂà(3.61 ÃÂà%) ÃÂàand ÃÂàcervical ÃÂàwas ÃÂàRpÃÂà1,416,027 (8.87 %). The results indicated ÃÂàthat the hospital needs ÃÂàto pay ÃÂàmore attention ÃÂàonÃÂànausea-vomiting effect of chemotherapy, and also cervical cancer side effects therapy as theÃÂàmost costly.Keywords: Cost Analysis, Cancer, Side Effects, Prof. Dr. Margono Soekarjo Hospital |